{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:06:14Z","timestamp":1765609574876},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T00:00:00Z","timestamp":1382313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2050-6511-14-55","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T13:09:49Z","timestamp":1382360989000},"source":"Crossref","is-referenced-by-count":7,"title":["Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands"],"prefix":"10.1186","volume":"14","author":[{"given":"Mari\u00ebtte","family":"Hooiveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine","family":"van de Groep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo JM","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne AB","family":"van der Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot AJB","family":"Tacken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit A","family":"van Essen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,21]]},"reference":[{"key":"281_CR1","volume-title":"Continuous Morbidity Registration at Dutch Sentinel General Practice Network 2009","author":"GA Donker","year":"2011","unstructured":"Donker GA: Continuous Morbidity Registration at Dutch Sentinel General Practice Network 2009. 2011, NIVEL: Utrecht"},{"key":"281_CR2","volume-title":"Global Alert and Respons (GAR) - Pandemic (H1N1)","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Global Alert and Respons (GAR) - Pandemic (H1N1). 2009, [\n                    http:\/\/www.who.int\/csr\/disease\/swineflu\/updates\/en\/index.html\n                    \n                  ], \u2013 full list of updates"},{"key":"281_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/eurpub\/ckq187","volume":"22","author":"CC Wielders","year":"2012","unstructured":"Wielders CC, van Lier EA, van \u2018t Klooster TM, van Gageldonk-Lafeber AB, van den Wijngaard CC, Haagsma JA, Donker GA, Meijer A, van der Hoek W, Lugn\u00e9r AK, Kretzschmar ME, van der Sande MA: The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health. 2012, 22: 150-157. 10.1093\/eurpub\/ckq187.","journal-title":"Eur J Public Health"},{"key":"281_CR4","doi-asserted-by":"crossref","first-page":"pii:19461","DOI":"10.2807\/ese.15.02.19461-en","volume":"15","author":"TM van \u2018t Klooster","year":"2010","unstructured":"van \u2018t Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, van der Sande MA, van der Hoek W: Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June \u2013 31 December 2009. Euro Surveill. 2010, 15: pii:19461-","journal-title":"Euro Surveill"},{"key":"281_CR5","volume-title":"Clinical management of human infection with pandemic (H1N1) 2009: revised guidance","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. 2009, Geneva: WHO"},{"key":"281_CR6","volume-title":"Influenza vaccination: revision of the indication. Publication no. 2007\/09","author":"Health Council of the Netherlands","year":"2007","unstructured":"Health Council of the Netherlands: Influenza vaccination: revision of the indication. Publication no. 2007\/09. 2007, The Hague: Health Council of the Netherlands"},{"key":"281_CR7","unstructured":"Stirbu-Wagner I, Dorsman SA, Visscher S, Davids R, Gravestein JV, Abrahamse H, van Althuis T, Jansen B, Schlief A, Tiersma W, Walk C, Wentink E, Wennekes L, Braspenning J, Korevaar JC: The Netherlands Information Network of General Practice. Facts and numbers in primary care [in Dutch]. Utrecht\/Nijmegen: NIVEL\/IQ; 2010. [\n                    http:\/\/www.linh.nl\n                    \n                  ]"},{"key":"281_CR8","volume-title":"ICPC. International Classification of Primary Care","year":"1987","unstructured":"ICPC. International Classification of Primary Care. Edited by: Lamberts H, Wood M. 1987, Oxford: Oxford University Press"},{"key":"281_CR9","volume-title":"Guidelines for ATC classification and DDD assignment 2010","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2009","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment 2010. 2009, Oslo: Norwegian Institute of Public Health"},{"key":"281_CR10","volume-title":"Monitoring vaccination rate Dutch national influenza prevention program 2009 [in Dutch]","author":"M Tacken","year":"2010","unstructured":"Tacken M, Mulder J, Visscher S, Tiersma W, Donkers J, Verheij R, Braspenning J: Monitoring vaccination rate Dutch national influenza prevention program 2009 [in Dutch]. 2010, LINH: Nijmegen\/Utrecht"},{"key":"281_CR11","volume-title":"Huisarts Wet","author":"GA Van Essen","year":"2008","unstructured":"Van Essen GA, Bueving HJ, Voordouw ACG, Berg HF, Van der Laan JR, de Jeude CP VL, Boomsma LJ, Opstelten W: Dutch College of General Practitioners-guideline influenza and influenza vaccination (first revision) [in Dutch]. Huisarts Wet. 2008, 51: appendix 1\u20132"},{"key":"281_CR12","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.vaccine.2004.02.017","volume":"22","author":"MAJB Tacken","year":"2004","unstructured":"Tacken MAJB, Braspenning JCC, Berende A, Hak E, De Bakker DH, Groenewegen PP, Grol RP: Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics - analysis of routinely collected data. Vaccine. 2004, 22: 2985-2992. 10.1016\/j.vaccine.2004.02.017.","journal-title":"Vaccine"},{"key":"281_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1006\/pmed.2002.1083","volume":"35","author":"M Tacken","year":"2002","unstructured":"Tacken M, Braspenning J, Spreeuwenberg P, Van den Hoogen H, Van Essen G, De Bakker D, Grol R: Patient characteristics determine differences in the influenza vaccination rate more so than practice features. Prev Med. 2002, 35: 401-406. 10.1006\/pmed.2002.1083.","journal-title":"Prev Med"},{"key":"281_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3201\/eid1803.111351","volume":"18","author":"EH Fietj\u00e9","year":"2012","unstructured":"Fietj\u00e9 EH, Philbert D, van Geffen EC, Winters NA, Bouvy ML: Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands. Emerg Infect Dis. 2012, 18: 534-535. 10.3201\/eid1803.111351.","journal-title":"Emerg Infect Dis"},{"issue":"154","key":"281_CR15","first-page":"74","volume":"2011","author":"AL Hersh","year":"2009","unstructured":"Hersh AL, Stafford RS: Antiviral prescribing by office-based physicians during the, H1N1 pandemic. Ann Intern Med. 2009, 2011 (154): 74-76.","journal-title":"Ann Intern Med"},{"key":"281_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3310\/hta14340-02","volume":"14","author":"L Yates","year":"2010","unstructured":"Yates L, Pierce M, Stephens S, Mill AC, Spark P, Kurinczuk JJ, Valappil M, Brocklehurst P, Thomas SH, Knight M: Influenza A\/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess. 2010, 14: 109-182.","journal-title":"Health Technol Assess"},{"key":"281_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/00365548.2011.619997","volume":"44","author":"M Aziz","year":"2012","unstructured":"Aziz M, Vasoo S, Aziz Z, Patel S, Eltoukhy N, Singh K: Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria. Scand J Infect Dis. 2012, 44: 306-311. 10.3109\/00365548.2011.619997.","journal-title":"Scand J Infect Dis"},{"key":"281_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/bmj.317.7162.858","volume":"317","author":"R Grol","year":"1998","unstructured":"Grol R, Dalhuijsen J, Thomas S, in\u2019t Veld C, Rutten G, Mokkink H: Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ. 1998, 317: 858-861.","journal-title":"BMJ"},{"key":"281_CR19","volume-title":"Annual report surveillance respiratory infections","author":"F Dijkstra","year":"2010","unstructured":"Dijkstra F, van \u2018t Klooster TM, Brandsema P, van Gageldonk-Lafeber AB, Meijer A, van der Hoek W: Annual report surveillance respiratory infections. 2010, Bilthoven: RIVM, [in Dutch]"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-6511-14-55\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-14-55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:49:16Z","timestamp":1548128956000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/2050-6511-14-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1186\/2050-6511-14-55","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,21]]},"article-number":"55"}}